Repros (RPRX) Files 5.75M Common Shelf

Repros Therapeutics, Inc. (Nasdaq: RPRX), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to a proposed 5.75 million shares of Common Stock.

The offering will be made through Ladenburg Thalmann & Co. Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Leader's Advantage Acquisition Corp. closes $150M IPO on Nasdaq
• DraftKings replaces BDO with Deloitte as its auditor for fiscal 2027
• Delek US prices $400M in convertible notes due 2031